TY - JOUR
T1 - Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP
AU - ADNP Consortium
AU - Van Dijck, Anke
AU - Vulto-van Silfhout, Anneke T.
AU - Cappuyns, Elisa
AU - van der Werf, Ilse M.
AU - Mancini, Grazia M.
AU - Tzschach, Andreas
AU - Bernier, Raphael
AU - Gozes, Illana
AU - Eichler, Evan E.
AU - Romano, Corrado
AU - Lindstrand, Anna
AU - Nordgren, Ann
AU - Bakshi, Madhura
AU - Wilson, Meredith
AU - Berman, Yemina
AU - Dickson, Rebecca
AU - Fransen, Erik
AU - Helsmoortel, Céline
AU - Van den Ende, Jenneke
AU - Van der Aa, Nathalie
AU - van de Wijdeven, Marina J.
AU - Rosenblum, Jessica
AU - Monteiro, Fabíola
AU - Kok, Fernando
AU - Quercia, Nada
AU - Bowdin, Sarah
AU - Dyment, David
AU - Chitayat, David
AU - Alkhunaizi, Ebba
AU - Boonen, Susanne E.
AU - Keren, Boris
AU - Jacquette, Aurelia
AU - Faivre, Laurence
AU - Bezieau, Stephane
AU - Isidor, Bertrand
AU - Rieß, Angelika
AU - Moog, Ute
AU - Lynch, Sally Ann
AU - McVeigh, Terri
AU - Elpeleg, Orly
AU - Smeland, Marie Falkenberg
AU - Fannemel, Madeleine
AU - van Haeringen, Arie
AU - Maas, Saskia M.
AU - Veenstra-Knol, H. E.
AU - Schouten, Meyke
AU - Willemsen, Marjolein H.
AU - Marcelis, Carlo L.
AU - Ockeloen, Charlotte
AU - van der Burgt, Ineke
N1 - Publisher Copyright:
© 2018 Society of Biological Psychiatry
PY - 2019/2/15
Y1 - 2019/2/15
N2 - Background: In genome-wide screening studies for de novo mutations underlying autism and intellectual disability, mutations in the ADNP gene are consistently reported among the most frequent. ADNP mutations have been identified in children with autism spectrum disorder comorbid with intellectual disability, distinctive facial features, and deficits in multiple organ systems. However, a comprehensive clinical description of the Helsmoortel-Van der Aa syndrome is lacking. Methods: We identified a worldwide cohort of 78 individuals with likely disruptive mutations in ADNP from January 2014 to October 2016 through systematic literature search, by contacting collaborators, and through direct interaction with parents. Clinicians filled in a structured questionnaire on genetic and clinical findings to enable correlations between genotype and phenotype. Clinical photographs and specialist reports were gathered. Parents were interviewed to complement the written questionnaires. Results: We report on the detailed clinical characterization of a large cohort of individuals with an ADNP mutation and demonstrate a distinctive combination of clinical features, including mild to severe intellectual disability, autism, severe speech and motor delay, and common facial characteristics. Brain abnormalities, behavioral problems, sleep disturbance, epilepsy, hypotonia, visual problems, congenital heart defects, gastrointestinal problems, short stature, and hormonal deficiencies are common comorbidities. Strikingly, individuals with the recurrent p.Tyr719* mutation were more severely affected. Conclusions: This overview defines the full clinical spectrum of individuals with ADNP mutations, a specific autism subtype. We show that individuals with mutations in ADNP have many overlapping clinical features that are distinctive from those of other autism and/or intellectual disability syndromes. In addition, our data show preliminary evidence of a correlation between genotype and phenotype.
AB - Background: In genome-wide screening studies for de novo mutations underlying autism and intellectual disability, mutations in the ADNP gene are consistently reported among the most frequent. ADNP mutations have been identified in children with autism spectrum disorder comorbid with intellectual disability, distinctive facial features, and deficits in multiple organ systems. However, a comprehensive clinical description of the Helsmoortel-Van der Aa syndrome is lacking. Methods: We identified a worldwide cohort of 78 individuals with likely disruptive mutations in ADNP from January 2014 to October 2016 through systematic literature search, by contacting collaborators, and through direct interaction with parents. Clinicians filled in a structured questionnaire on genetic and clinical findings to enable correlations between genotype and phenotype. Clinical photographs and specialist reports were gathered. Parents were interviewed to complement the written questionnaires. Results: We report on the detailed clinical characterization of a large cohort of individuals with an ADNP mutation and demonstrate a distinctive combination of clinical features, including mild to severe intellectual disability, autism, severe speech and motor delay, and common facial characteristics. Brain abnormalities, behavioral problems, sleep disturbance, epilepsy, hypotonia, visual problems, congenital heart defects, gastrointestinal problems, short stature, and hormonal deficiencies are common comorbidities. Strikingly, individuals with the recurrent p.Tyr719* mutation were more severely affected. Conclusions: This overview defines the full clinical spectrum of individuals with ADNP mutations, a specific autism subtype. We show that individuals with mutations in ADNP have many overlapping clinical features that are distinctive from those of other autism and/or intellectual disability syndromes. In addition, our data show preliminary evidence of a correlation between genotype and phenotype.
KW - ADNP
KW - Autism
KW - Genetics
KW - Helsmoortel-Van der Aa syndrome
KW - Intellectual disability
KW - Neurodevelopmental disorder
UR - http://www.scopus.com/inward/record.url?scp=85046376065&partnerID=8YFLogxK
U2 - 10.1016/j.biopsych.2018.02.1173
DO - 10.1016/j.biopsych.2018.02.1173
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29724491
AN - SCOPUS:85046376065
SN - 0006-3223
VL - 85
SP - 287
EP - 297
JO - Biological Psychiatry
JF - Biological Psychiatry
IS - 4
ER -